Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osilodrostat in Mild Autonomous Cortisol Secretion
NCT07104812Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of osilodrostat in Autonomous Cortisol Secretion (ACS), sponsored by Mayo Clinic. Started Jan 2026; status: recruiting.
02
Drugs
osilodrostat
03
Conditions
Autonomous Cortisol Secretion (ACS)
Beyond the preview
Go deeper on NCT07104812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104812.